Beigene, LTD. (BEIGF) — SC 13D/A Filings
All SC 13D/A filings from Beigene, LTD.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (3)
-
Baker Bros. Advisors Adjusts BeiGene Stake
— Dec 10, 2024 Risk: medium
Baker Bros. Advisors LP, through its affiliates FBB3 LLC and Baker Bros. Advisors (GP) LLC, has amended its Schedule 13D filing concerning BeiGene, Ltd. as of D -
HHLR Advisors Ups BeiGene Stake to 10.4%
— Dec 4, 2024 Risk: medium
On December 4, 2024, HHLR Advisors, Ltd. filed an amendment (No. 5) to its Schedule 13D concerning BeiGene, Ltd. The filing indicates a change in beneficial own -
BeiGene, Ltd. Amends Schedule 13D/A for Leap Therapeutics
— Oct 31, 2024 Risk: medium
BeiGene, Ltd. has filed an amendment (Amendment No. 2) to its Schedule 13D/A regarding Leap Therapeutics, Inc. The filing, dated October 31, 2024, indicates a c
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX